By bringing a game-changing, patient-centred solution to diabetes management in India, Cipla will make this drug ... acting insulin delivered through an inhaler compared to current insulins ...

Following g-Proventil’s approval and successful completion of g-Advair’s Phase-3 clinical study, we believe CIPLA is well poised to expand its inhaler portfolio in the US market. We raise our ...